UnitedHealth Group Incorporated (NYSE:UNH) had its price target lifted by equities researchers at Oppenheimer Holdings, Inc. from $215.00 to $205.00 in a report released on Wednesday. The firm currently has an “outperform” rating on the healthcare conglomerate’s stock. Oppenheimer Holdings, Inc.’s price objective suggests a potential downside of 0.11% from the stock’s previous close.

Several other analysts have also recently commented on UNH. Morgan Stanley upped their target price on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. Stifel Nicolaus reiterated a “buy” rating and issued a $185.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 28th. Cantor Fitzgerald reiterated a “buy” rating and issued a $205.00 target price on shares of UnitedHealth Group in a report on Friday, July 7th. BidaskClub upgraded UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 8th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $212.40.

Shares of UnitedHealth Group (UNH) traded up 0.66% on Wednesday, hitting $205.23. 4,796,301 shares of the stock traded hands. The stock has a 50 day moving average of $196.56 and a 200-day moving average of $184.87. The stock has a market cap of $198.43 billion, a PE ratio of 24.66 and a beta of 0.63. UnitedHealth Group has a 1-year low of $133.03 and a 1-year high of $207.80.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the prior year, the business posted $2.17 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group will post $9.91 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) PT Raised to $205.00 at Oppenheimer Holdings, Inc.” was reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/10/18/unitedhealth-group-incorporated-unh-pt-raised-to-205-00-at-oppenheimer-holdings-inc.html.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares in the company, valued at approximately $14,753,730.84. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock valued at $14,981,909 in the last quarter. 0.89% of the stock is owned by corporate insiders.

Large investors have recently added to or reduced their stakes in the business. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $114,000. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares in the last quarter. Finally, BDO Wealth Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $121,000. 86.11% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.